Altitude Crest Partners Inc.
- SEC CIK
- 0001986035
- Latest filing
- Feb 14, 2025
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only.
- Positions
- 12
- No filing for Q3 2023
- Portfolio value
- $149.4M
- No filing for Q3 2023
Altitude Crest Partners Inc. did not file a 13F for Q3 2023, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| LEGNLegend Biotech Corp | SPONSORED ADS | 541,816 | $32.6M | 21.8% | – | – | History |
| BBIOBridgeBio Pharma, Inc. | COM | 754,560 | $30.5M | 20.4% | – | – | History |
| DHRDanaher Corp | Stock | 121,600 | $28.1M | 18.8% | – | – | History |
| ARGXArgenx SE | SPONSORED ADR | 29,500 | $11.2M | 7.5% | – | – | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 114,042 | $11.0M | 7.4% | – | – | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 152,200 | $9.11M | 6.1% | – | – | History |
| ROIVRoivant Sciences Ltd. | SHS | 808,061 | $9.07M | 6.1% | – | – | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 456,041 | $8.00M | 5.4% | – | – | History |
| EXASExact Sciences Corp | COM | 99,130 | $7.33M | 4.9% | – | – | History |
| ALGSAligos Therapeutics, Inc. | COM | 2,844,681 | $1.89M | 1.3% | – | – | History |
| AMAMAmbrx Biopharma, Inc. | COM | 43,100 | $613.7K | 0.4% | – | – | History |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 384,573 | $7.69K | <0.1% | – | – | – |